Skeletonisation contributing to a reduction of sternal wound complications: a retrospective study in OPCAB patients

Table 5 Outcomes: sternal wound complication incidence and grade and overall survival in the diabetes subgroup

Variable	Non-skeletonized (n = 414)	Skeletonized (n = 141)	Odds ratio (95% CI)	P
SWC incidence	82 (19.81)	12 (8.51)	0.38 (0.20;0.71)	0.003
			0.46 (0.24;0.88)^a	0.019^a
SWC incidence (grade 1 excluded)	53 (12.80)	8 (5.67)	0.41 (0.19;0.88)	0.023
			0.47 (0.22;1.03)^a	0.058^a
SWC grade			0.38 (0.20;0.71)	0.003
			0.45 (0.24;0.87)^a	0.018^a
SWC grade (grade 1 excluded)			0.41 (0.19;0.88)	0.022
			0.47 (0.21;1.02)^a	0.055^a
1	29 (7.00)	4 (2.84)
2	11 (2.66)	3 (2.13)
3	32 (7.73)	4 (2.84)
4	10 (2.42)	1 (0.71)
Overall survival (%, 95 CI)			0.74 (0.21;2.54)	0.630
			0.67 (0.19;2.32)^a	0.529^a
1 month	97.42 (95.26;98.61)	100.00
6 months	95.02 (92.20;96.84)	98.04 (86.88;99.72)
12 months	95.02 (92.20;96.84)	89.13 (54.65;97.83)

ISSN: 1749-8090